Title:
Cancer and host immunity (microbiome)
Biography
Ivana Haluskova Spent over 1115 years in senior position in pharma industry career in research and industry and consultancy covering complex international projects from proof of concept to phase IV in Europe, Asia and US including the oncology domain as well as having worked in various other therapeutic areas including pediatrics, rare diseases, infectious diseases, vaccines and inflammation. Gained medical, academia and industry experience in Europe, Israel but mainly in Asia and US including the oncology domain as well as having worked in various other therapeutic areas including pediatrics, rare diseases, infectious diseases, vaccines and inflammation. . Board certified in internal medicine, immunology and infectious diseases and graduated in the Slovak Republic. French Physician. increasing immune surveillance and responsiveness to treatment. accurate diagnostic and intervention empowering host immune response, The use of antibiotic inteligent fashion, microbiome as adjuvant, oncomimetics to inspire new way to tackle cancer ( v a c c i n e s - l i k e o n c o m i m e t i c b u t m o r e ) while considering acurate diagnostic,individual particularities are important and worth deeper understanding for best care of patients. Microbiome plays role in currently used immunotherapy and CAART based on scientific data. An administrative Board member of multiple scientific societies that focus on immunology, including vaccins, immuno-oncology and infectiousdiseases crosslinks: French society of immunology, the Center of Global Health India and World alliance against resistance based in Paris. Regular speaker at various conferences highlighting the role of immunology, microbiota (boosting host immunity.)